CD1C, TNFSF10, C6ORF10, and UBASH3A have the potential to be used as RA risk markers (Julia et al., 2017; Anaparti et al., 2019; Guderud et al., 2020). This evidence concerns the gene CD1C and rheumatoid arthritis.